hero media helmsley

Our Grants

GRANT DATE AMOUNT PROGRAM
Kaiser Foundation Health Plan of Georgia, Inc.
Expansion of the T1DES Pilot to a Public Hospital
04.26.2023 $546,967.00 Type 1 Diabetes, Improve Outcomes
The Imperial College of Science, Technology and Medicine
Immunological mechanisms underlying the genetic basis for natural T1D protection
04.12.2023 $1,112,592.00 Type 1 Diabetes, Prevent & Delay
American Diabetes Association, Inc.
Training and Mentorship Programs
03.14.2023 $2,416,146.00 Type 1 Diabetes, Improve Outcomes
DreaMed Diabetes Ltd.
Increasing access to decision support tools for improved insulin dosing for people with diabetes
02.23.2023 $2,850,000.00 Type 1 Diabetes, Improve Outcomes
University Hospitals Health System, Inc.
Type 1 Diabetes Financial Toolkit for Emerging Adults
02.22.2023 $2,251,238.00 Type 1 Diabetes, Improve Outcomes
Beyond Type 1
Capacity Building Support
02.22.2023 $4,400,000.00 Type 1 Diabetes, Improve Outcomes
World Health Organization
Strengthening the Capacity of the Global Diabetes Compact
01.11.2023 $10,680,670.00 Type 1 Diabetes, Improve Outcomes
JDRF Australia
ENDIA Follow up 2023-2025 + Samples Analysis RFA
11.08.2022 $4,790,735.00 Type 1 Diabetes, Prevent & Delay
The Trustees of Columbia University in the City of New York
Support for T1D Transition Programs
11.08.2022 $600,000.00 Type 1 Diabetes, Improve Outcomes
Center for Health Care Strategies Inc
CGM Medicaid Access Accelerator - Targeted Resources and Technical Assistance to Improve Care for People Living with Diabetes Who Use Insulin
11.08.2022 $2,282,795.00 Type 1 Diabetes, Improve Outcomes
HealthPartners Institute
Piloting the Process of Electronically Collecting Patient Generated Continuous Glucose Monitoring Data to Accelerate the Development of New Diabetes-Related Measure Concepts
11.08.2022 $751,067.00 Type 1 Diabetes, Improve Outcomes
American College of Diabetology Inc
Improve the diabetes training opportunities for PCPs
11.08.2022 $2,991,988.00 Type 1 Diabetes, Improve Outcomes
Medical University of South Carolina
Engineered dendritic cell based robust antigen specific therapy for type 1 diabetes
11.08.2022 $825,000.00 Type 1 Diabetes, Prevent & Delay
University of Florida
Human Atlas of Neonatal Development and Early Life-Immunity (HANDEL-I) continuation
11.08.2022 $2,072,489.00 Type 1 Diabetes, Prevent & Delay
University of North Carolina at Chapel Hill
Development of a Continuous Insulin Sensor
11.08.2022 $3,163,533.00 Type 1 Diabetes, Improve Outcomes
Mayo Clinic
Development and Evaluation of a Novel Algorithm for AID control for Pregnant Women with T1D
11.08.2022 $1,081,500.00 Type 1 Diabetes, Improve Outcomes
Oregon Health & Science University
An MDI Decision Support System with CDCES and Behavioral Health Support
10.25.2022 $4,364,007.00 Type 1 Diabetes, Improve Outcomes
King's College London
Prenatal drivers of infant ISlet Autoimmunity (PISA study)
10.25.2022 $2,422,655.00 Type 1 Diabetes, Prevent & Delay
King's College London
Characterising ‘NoGo Autoimmunity' in genetically protected (HLA-DQ6+) subjects
10.25.2022 $757,700.00 Type 1 Diabetes, Prevent & Delay
Region Hovedstaden
Can microchimerism explain differences in parental type 1 diabetes conferred risk of offspring type 1 diabetes?
10.25.2022 $592,935.00 Type 1 Diabetes, Prevent & Delay
You can filter rows:
1 - 20 of 820 <   > Last